- Posts:
- 0 (N/A per day)
- Age:
- N/A
- Date Registered:
- Yesterday at 14:38:56
- Local Time:
- 2025-06-28, 01:39:29
- Last Active:
- Yesterday at 18:51:17
Signature:
These findings further validate the utility of targeting myeloid NF-κB p50 as a strategy for cancer therapy and demonstrate activity of p50-IMC g